Mdficem#Nlh
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Mdficem#Nlh |
| Name: |
MyoD family inhibitor domain containing; endonuclease-mediated mutation, Natasha L Harvey |
| MGI ID: |
MGI:7314724 |
| Synonyms: |
MdficM131fs* |
| Gene: |
Mdfic Location: Chr6:15720660-15802168 bp, + strand Genetic Position: Chr6, 6.85 cM
|
| Alliance: |
Mdficem#Nlh page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence) |
| Mutation: |
|
Intragenic deletion
|
| |
|
Mutation details: CRISPR/Cas9 technology targeting the region between c.379G and c.396C generated deletion alleles. This record represents the pooled data of two lines, one containing a 2 bp deletion Mdficem1Nlh and one an 8 bp deletion Mdficem2Nlh in this region resulting in a frameshift and premature stop codon. This mimics the common mutation in humans c.391dup (p.Met131Asnfs*3).
(J:326462)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Mdfic Mutation: |
30 strains or lines available
|
|
| Original: |
J:326462 Byrne AB, et al., Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema. Sci Transl Med. 2022 Mar 2;14(634):eabm4869 |
| All: |
1 reference(s) |
|